Xiushan Sun
  1. Registered Foreign Lawyer

Ms. Sun is an associate in Davis Polk’s Corporate Department, currently practicing as a Registered Foreign Lawyer in Hong Kong.

Work Highlights

  • Ocumension Therapeutics' $200.4 million Hong Kong IPO and global offering
  • Shenzhen Hepalink Pharmaceutical's $523 million Hong Kong IPO and global offering
  • Akeso, Inc's $312 million Hong Kong IPO and global offering
  • Venus Medtech's $331 million Hong Kong IPO and global offering 
  • Future Land Development Holding’s $300 million high-yield notes offering
  • China Evergrande Group’s:
    • $200 million notes offering
    • $1 billion senior notes offering
    • $1.8 billion high-yield senior notes offering
  • Sea Limited’s $1.5 billion follow-on offering of American Depositary Shares
  • China Aoyuan Group’s $500 million high-yield senior notes offering
  • Oceanwide Holdings International Development III’s $215 million notes offering

Professional History

  • Davis Polk since 2018

Practice Focus

Bar Admissions

  • State of New York
  • Hong Kong Law Society - Registered

Education

  • LL.B., Peking University, 2014
  • J.D., Georgetown University Law Center, 2017
  • J.D./LL.M., Georgetown University Law Center, 2018